Evolent Health EVH Cash Flow Statement (2014-2026)

NYSE EVH
$4.47 -0.10 (-2.08%)
As of: Oct 19, 2026 · 3:59 PM EDT
Reported Financials

Evolent Health Quarterly Cash Flow Statement

Periods 49 quarters
Latest Jun 2026

Evolent Health reported cash from operations of -$9.31M and free cash flow of -$16.16M for the quarter ended Jun 2026, up 69.3% year over year. This cash flow statement covers 49 quarters of results from Jun 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-13.04M-5.65M-5.35M-4.59M2.12M-11.35M-19.98M-34.32M-25.32M-33.41M-17.28M1.60M-23.14M-22.80M-64.62M-19.90M-20.86M-429.13M-26.63M-28.36M
Depreciation and DepletionDep. & Depletion
7.40M7.80M7.60M7.80M7.70M8.90M8.10M8.20M8.50M7.60M7.50M7.90M7.50M7.40M7.30M6.40M6.30M6.30M6.30M6.30M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
4.56M4.65M11.69M1.50M1.58M8.29M2.29M3.38M2.33M2.94M1.21M1.11M1.29M1.19M1.24M1.29M3.18M2.10M2.95M2.98M
Depreciation & Amortization (CF)Dep. & Amort.
14.86M14.92M15.11M15.11M17.20M19.78M29.28M32.13M32.40M29.60M29.50M29.87M29.70M29.30M24.06M23.14M23.62M45.04M21.56M21.57M
Share-based CompensationStock Comp.
4.40M4.96M5.35M7.01M6.99M14.63M10.71M8.97M10.22M10.60M18.79M12.66M14.42M-6.12M11.08M11.58M14.68M2.40M10.65M15.20M
Deferred Taxes
-0.02M-0.24M-0.13M0.60M-46.86M0.78M-68.73M-2.29M-7.18M-15.06M0.18M-1.16M-0.94M-1.07M0.30M-0.87M0.63M-3.04M0.58M2.39M
Gains from Equity InvestmentsGains Equity
0.10M0.48M0.60M2.00M1.40M0.66M0.42M0.20M0.70M0.31M-1.70M-2.23M0.18M-0.02M0.20M0.20M0.07M-0.01M-0.04M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
24.07M2.59M
Other non-cash itemsOther Non-Cash
-0.23M-5.14M5.72M0.80M-2.51M-27.44M8.51M-7.82M11.30M5.89M8.91M0.20M14.72M53.98M3.40M-2.75M5.11M
Change in Working Capital
Change in ReceivablesChange Receivables
-67.19M-47.10M46.30M-59.34M47.84M68.18M-19.83M82.97M49.04M52.52M-19.01M-54.01M34.18M6.78M15.82M-71.74M48.56M-66.34M4.30M134.96M
Change in Account PayablesChange Payables
-1.74M-0.91M0.43M-1.25M6.76M7.23M-13.59M0.85M0.10M5.91M-8.42M-6.91M16.59M2.99M3.26M14.93M3.31M-14.86M5.39M-23.20M
Change in Accured ExpensesChange Accured Exp.
7.61M17.43M-32.44M7.61M-3.08M-0.89M-31.40M10.76M48.18M-3.88M-27.28M2.21M0.29M0.58M-18.88M13.01M27.53M-4.39M-20.98M-1.37M
Change in Other Operating AssetsOther Assets Change
-0.64M2.37M5.46M6.95M-4.10M-4.79M10.46M12.39M-13.63M-9.63M-6.80M2.55M-1.55M4.09M8.51M-5.85M-0.86M-1.60M3.99M0.91M
Change in Other Operating LiabilitiesOther Liabilities Change
-47.40M-30.30M-8.22M-41.03M6.50M59.98M-5.89M52.21M42.37M99.24M-37.90M-60.90M-8.52M2.87M15.11M-166.91M14.92M-19.11M32.84M138.26M
Other Working Capital ChangesOther WC Changes
-46.76M-32.67M-13.68M-47.98M10.60M64.77M-16.36M39.82M56.00M108.87M-31.09M-63.44M-6.98M-1.22M6.60M-161.06M15.78M-17.51M28.85M137.35M
Cash from OperationsCash from Ops.
44.50M66.66M-57.44M13.66M-3.47M35.70M-7.97M0.65M60.52M89.38M4.91M21.42M18.67M-26.23M4.57M-30.33M15.81M48.80M-0.98M-9.31M
Investing Activities
Capital ExpendituresCapex
6.23M7.24M8.51M9.24M9.87M10.74M9.06M6.85M6.79M6.05M5.35M7.11M6.29M6.15M8.60M8.77M8.96M7.76M6.41M6.85M
Change in Property, Plant and EquipmentChange in PP&E
-6.23M-7.24M-8.51M-9.24M-9.87M-10.74M-9.06M-6.85M-6.79M-6.05M-5.35M-7.11M-6.29M-6.15M-8.60M-8.77M-8.96M-7.76M-6.41M-6.85M
Acquisitions
0.42M47.12M0.07M9.00M235.95M3.09M386.72M1.52M1.39M4.56M11.00M13.78M4.50M51.55M0.00M1.40M
Divestments
22.97M8.00M
Net of Acquisitions & DivestmentsNet Acquisitions
-0.42M-47.12M22.90M-9.00M-235.95M4.91M-386.72M-1.52M-1.39M-4.56M-11.00M-13.78M-4.50M-51.55M0.00M-1.40M
Purchase of InvestmentsInvestments Purchased
0.00M3.00M1.88M2.44M0.00M1.00M
Sale and Maturity of InvestmentsInvestments Sold
4.85M2.38M1.80M1.38M0.79M0.01M0.07M0.01M0.20M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-1.80M-54.37M16.77M-16.44M-254.99M-4.46M-394.99M-8.35M-6.15M-6.05M-9.73M-13.54M-19.73M-19.93M-13.09M-60.53M-8.76M82.15M-6.41M-6.70M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
219.74M256.33M-0.27M391.43M
Long-Term Debt RepaymentsLT Debt Repayment
-98.42M98.42M37.50M10.00M416.70M62.50M166.76M113.73M10.00M
Non-Current Debt
98.42M-98.42M219.74M218.83M-0.27M-10.00M-25.27M-62.50M-166.76M-113.73M-10.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
98.42M-98.42M219.74M218.83M-0.27M-10.00M-25.27M-62.50M-166.76M-113.73M-10.00M
Change in Capital Stock
Common Stock IssuedStock Issued
2.19M1.72M0.31M2.97M1.17M1.58M3.07M4.53M3.34M1.06M0.06M2.34M0.00M
Net Shares Issued and RepurchasedNet Shares Issued
2.19M1.72M0.31M2.97M1.17M1.58M3.07M4.53M3.34M1.06M0.06M2.34M0.00M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
168.00M
Net Equity Issued and RepurchasedNet Equity Issued
2.19M1.72M0.31M2.97M1.17M169.58M3.07M4.53M3.34M1.06M0.06M2.34M0.00M
Dividend Payments
Dividends Paid - PreferredDiv. Paid (Pref.)
3.65M4.88M5.10M5.16M5.08M5.07M5.13M4.81M4.58M4.62M1.93M
Dividends Paid - Common and PrefferdDiv Paid (Total)
3.65M4.88M5.10M5.16M5.08M5.07M5.13M4.81M4.58M4.62M1.93M
Other financing activitiesOther financing
-1.55M158.02M-51.69M20.69M-49.63M-12.03M-5.03M25.41M-26.80M-57.26M19.43M-98.38M-6.22M42.64M-46.07M-4.31M-1.88M2.39M-3.97M-0.99M
Cash from Financing ActivitiesCash from Financing
0.64M60.90M-51.38M20.69M173.08M-10.85M379.73M23.33M-37.37M-84.35M14.88M-103.38M-9.01M96.94M107.85M-8.93M-41.82M-93.04M-3.97M-10.99M
Additional items
Exchange Rate EffectFX Effect
0.00M0.00M-0.10M-0.27M-0.24M-0.05M0.05M0.00M-0.11M-0.02M-0.04M-0.02M-0.03M-0.14M0.02M-0.08M-0.20M-0.23M-0.59M-0.27M
Change in Cash
43.35M73.19M-92.16M17.65M-85.62M20.34M-23.19M15.63M16.90M-1.04M10.02M-95.53M-10.10M50.65M99.35M-99.88M-34.97M37.69M-11.95M-27.28M
Ending Cash Balance
281.76M354.94M262.79M280.43M194.82M215.16M191.97M207.60M224.50M223.46M233.48M137.95M127.85M178.50M277.85M177.97M143.00M180.70M168.74M141.50M
Free Cash FlowFCF
38.27M59.41M-65.95M4.43M-13.34M24.95M-17.03M-6.19M53.73M83.33M-0.44M14.31M12.38M-32.38M-4.03M-39.10M6.85M41.04M-7.39M-16.16M
Net Cash FlowNCF
43.34M73.19M-92.05M17.92M-85.38M20.39M-23.24M15.63M17.01M-1.02M10.06M-95.51M-10.07M50.78M99.33M-99.79M-34.77M37.92M-11.36M-27.00M

Evolent Health Cash Flow Statement API

Pull Evolent Health's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EVH&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY